This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Microneedle Drug Delivery Systems Market

Market Insights on Microneedle Drug Delivery Systems covering sales outlook, demand forecast & up-to-date key trends

Microneedle Drug Delivery Systems Market By Product (Solid Microneedles, Hollow Microneedles, Dissolving Microneedles), End Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics, Academic Institutions, Research Institutes) & Region - Forecast 2022 - 2030

Microneedle Drug Delivery Systems Market Outlook (2022-2030)

[238 Pages Report] Sales in the global microneedle drug delivery systems market are slated to increase at a healthy 6.6% CAGR over the forecast period, topping US$ 1.2 Bn by 2030, up from US$ 722.2 Mn in 2022.

Microneedle Drug Delivery Systems Market Size (2022)

US$ 722.2 Mn

Revenue Forecast (2030)

US$ 1.2 Bn

Global Market Growth Rate (2022-2030)

6.6% CAGR

Dominant End User

Hospitals (44.1%)

Microneedle drug delivery systems account for 5.8% share in the global special purpose needles market at present. Increasing prevalence of diabetes and infectious diseases and rising incidence of cancer and spine disorders across the globe are expected to shape microneedle drug delivery system demand over the years to come.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

6.46%

H1, 2022 Projected

6.60%

H1, 2022 Outlook

6.10%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 50 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 36 ↓

The comparative analysis and market growth rate of global microneedle drug delivery systems market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a decline in the BPS growth is expected in H1-2022 over H1- 2021 duration with 36 Basis Point Share (BPS).

The drop in the BPS values is associated with the high costs associated with the manufacturing of a microneedle patch with reproducibility, moreover, the high costs of containing and packaging microneedles for safe distribution is another restraining factor attributed towards the declining BPS values.

However, with the benefits of microneedles in advanced transdermal drug delivery by enhanced bioavailability of drugs, minimal side effects, and rapid onset of drug action, the market is set to gain traction towards growth over the forecasted years.

The key developments in the market include the launch of the solid, dissolving, and coated microneedles for effective transdermal drug delivery. The market for microneedle drug delivery systems is subject to changes as per the regulatory and industry dynamics with reference to the drug safety and product licensing activities.

Demand Analysis Microneedle Drug Delivery Systems (2015 To 2021) Vs Market Outlook (2022 To 2030)

Microneedles are extremely small needles used to deliver medicines. They are measured in millionths of a metre (m). The administration of vaccinations is one of the most promising applications for microneedles. Because of their transdermal penetration capabilities, microneedles are utilised in a wide range of low molecular weight medicines, vaccines, biotherapeutics, and protein pharmaceuticals.

The microneedle drug delivery devices market expanded at a CAGR of 6.3% from 2015 to 2021 and amassed revenue worth US$ 679.4 Mn in 2021.

Microneedles (MN) are gaining popularity as a new medicine delivery method. The job can be administered in a minimally invasive and pain-free manner using a microneedle-based system of drug delivery.

Microneedle Drug Delivery Systems Market Download Report Brochure

In light of this, increased diabetes cases are projected to benefit the market. In addition, a large number of needle stick injuries occur each year, which is projected to promote the uptake of microneedle drug delivery equipment.

According to a recent analysis released by Future Market Insights (FMI), the market for microneedle drug delivery systems is expected to top US$ 1.2 Bn by 2030, expanding at a CAGR of 6.6 % from 2020 to 2030.

As healthcare spending rises in developing economies, manufacturers have a great opportunity for marketing strategies, which will aid players in their efforts to extend their markets and develop a larger footprint.

Which Factors Make Microneedles For Drug Delivery Profitable?

“Advancement in Technologies & Cost-effectiveness Drive Demand for Microneedles for Drug Delivery from Various Sectors”

Microneedles with cutting-edge technology are predicted to be in high demand. The total expansion will be aided by factors such as cost-effectiveness, bioavailability, and the fast action of these technologies. Demand from many sectors is expected to rise as the healthcare sector seeks sophisticated and accurate ways for drug administration.

As a result, microneedle manufacturers will see demand in a variety of other disciplines, including pharmacological therapies, aesthetic therapies, and immunizations. The demand for diverse biomedical uses such as long-term disease therapy, disease detection, immune biological administration, and so on is increasing global market potential for microneedle drug delivery devices.

“Increasing Rate of Chronic Illnesses & Availability of Advanced Microneedles Boosting Sales of Microneedle Drug Delivery Systems”

Microneedle drug delivery systems are also finding use in the more accurate and regulated distribution of macromolecules including insulin, growth hormones, proteins, and others. With the number of apps on the rise, various producers are seeing attractive prospects to break into the industry.

The global microneedle drug delivery system market will be fueled by advancements in technologies such as microneedle patches and the rise in microneedles for transdermal drug delivery applications including pain treatment, congestive heart failure, and hormone replacement.

Rising prevalence of chronic illnesses and other life-threatening disorders is driving demand for new, effective medications in a variety of therapeutic areas. Injectable medications' ease and at-home accessibility are driving manufacturers and pharmaceutical companies to develop effective devices for treating a variety of disorders.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors Are Adversely Affecting Sales Of Microneedles For Drug Delivery?

“High Expenditure Cost & Unavailability of Skilled Medical Workers to Hinder Market Growth”

Despite their many advantages, microneedles have a few drawbacks that could slow the market's growth. Microneedle safety, for example, might be a source of concern at times. In addition, the efficacy of the microneedle drug delivery system may be hampered by varying skin permeability.

Because of concerns about their intrusive nature and stability, they must be administered by highly knowledgeable and trained medical professionals. Furthermore, the global market for microneedle drug delivery systems includes a small number of products that have been approved by regulatory agencies, which could impair the product's consistency and efficacy.

Furthermore, substantial financial expenditure necessary for product development makes it difficult for small market players and manufacturers to break into the industry. The microneedle drug delivery systems market is projected to be hampered by drug degradation, poor absorption, local discomfort, and absorption variability.

Which Regional Markets Are Expected To Be Profitable For Microneedle Drug Delivery Product Manufacturers?

“Ability of Consumers to Purchase Expensive Healthcare Products Make North America Prominent Region for Microneedle Drug Delivery Systems”

These microneedle drug delivery systems market insights shed light on the metrics for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).

The market for microneedle drug delivery systems in North America is predicted to expand at a robust CAGR over the forecast period. Because of increasing prevalence of chronic diseases, including diabetes, cancer, and others, the North America market is expected to account for a bigger portion of the global market by 2030.

Furthermore, product availability aids in the expansion of the microneedle drug delivery systems market in the region. One category of products that is expanding and emerging in the region is dissolving microneedles. Another reason why North America provides prospective market opportunities for manufacturers is the ability of consumers to afford these expensive products.

During the projected period, an increasing preference for biodegradable microneedle materials is expected to drive market expansion in Europe. Europe, driven by rising demand for innovative medical and treatment techniques, is likely to become a lucrative market as well. Throughout the projection period, Europe is expected to be the second-largest market for microneedle drug delivery devices.

After North America and Europe, East Asia has emerged as a highly attractive market for microneedle drug delivery systems. Increased investments in healthcare infrastructure and adoption of sophisticated technology will boost regional market expansion.

The East Asia market is expected to increase at a noticeable pace over the anticipated period due to the production of low-cost solid and hollow microneedles.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-Wise Analysis

How is the U.S. Microneedle Drug Delivery Systems Market Faring?

“Rising Number of Cancer Patients Driving Need of Microneedles for Drug Delivery”

Increased prevalence of chronic diseases in the United States, such as cancer and diabetes, is driving demand for smart and effective drug delivery solutions to improve treatment. This is attracting new product development to the country from manufacturers and research institutes, positioning it as a lucrative pocket.

In 2022, the United States will witness 1.9 Mn new cancer cases diagnosed and 609,360 cancer deaths, according to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), a scientific article published in the American Cancer Society journal. This is expected to encourage the development of new oncology treatments, boosting the market for microneedle drug delivery systems in the country.

Furthermore, presence of strong healthcare industry, public healthcare reimbursements, and online delivery of medical devices and drugs will continue to enhance the microneedle drug delivery systems market in the United States in the coming years.

Why is the China Microneedle Drug Delivery Systems Market Witnessing High Demand Growth?

“Demand for Top Quality Medications & Availability of Raw Materials at Low Rate Helps China to Expand its Market”

Over the projection period, China is expected to hold a prominent position in the East Asia market. Government bodies in China are increasing their investments in expanding the healthcare sector, creating a favourable climate for the development of innovative drugs in the country.

Because of the plentiful supply of low-cost raw materials and rising demand for branded pharmaceuticals, several multinational pharmaceutical companies are looking to expand their operations in China.

Furthermore, the biologics sector's rise will continue to drive market sales. The biologics industry's growing production of vaccines, insulin, gene and cellular therapies, growth inhibitors, and cytokines is driving the need for effective drug delivery systems, which, in turn, is boosting the microneedle drug delivery systems market in China.

Category-Wise Analysis

Which Product Type is Set to Gain Huge Popularity?

“Solid Microneedles Dominates Microneedle Drug Delivery Systems Market Growth”

Despite a minor drop in market share over the predicted period, solid microneedles continue to lead the industry. By the end of 2030, they are expected to have covered more than half of the market. Meanwhile, with the application of new technologies and uses, hollow and dissolving microneedles are expected to proliferate at a quicker rate.

Solid microneedle research is underway for a variety of applications in order to improve consistency, stability, and cost for solid microneedles. Development of a microneedle array is currently the focus of research.

This metallic microneedle array is now widely utilised in cosmetic therapies to treat acne, stretch marks, hair loss, and other conditions. Metallic microneedle arrays are being considered for the administration of COVID-19 vaccines, according to a recent study.

Which End Use Segment is Predicted to Flourish in the Microneedle Drug Delivery Systems Market?

“Hospitals Set to Account for Higher Consumption of Microneedles for Drug Delivery

Hospitals are expected to remain the leading end users accounting for 44.1% of the global market share in 2022. Specialty clinics are predicted to benefit the global microneedle drug delivery systems market in terms of growth.

In 2022, specialty clinics are expected to account for 22% of the global market share. Market potential is predicted to increase as the number of clinics specialising in certain illnesses grows. Cosmetic clinics, for example, are one of the largest users of microneedle drug delivery systems for wrinkle treatment, facelifts, hair loss treatment, and other procedures.

Ambulatory surgical facilities are also known as outpatient surgery centres where patients can have surgery the same day they are admitted without having to remain overnight. These facilities also provide diagnostic and preventative services.

Ambulatory surgical facilities are expected to account for 12.5% of the global market share in 2022 due to factors such as rise in the number of surgeries, increase in the frequency of chronic diseases, and increase in the elderly population.

Microneedles are widely used in research institutes for the delivery of drugs to get expected results. Research institutes are expected to account for 15.9% of the global market share (2022).

COVID-19 Impact On Market

The pandemic pushed the entire commercial ecosystem into disarray. Manufacturers of microneedle drug delivery systems were severely hampered by the absence of transportation, which brought production to a halt and disrupted supply chains.

Doctors and practitioners were also choosing to avoid any surgical treatments that were not absolutely and immediately necessary due to a variety of restrictions imposed by respective governments worldwide.

Furthermore, the cosmetic industry, which is another major user of microneedle drug delivery systems, was impacted because almost all of the treatments that fall under their umbrella were deemed non-urgent.

However thanks to the development of COVID-19 vaccines, it has expanded the market for microneedle drug delivery system manufacturers and providers. As a result, the microneedle drug delivery systems market has been predicted to expand at a noticeable pace during the forecast period.

Competitive Landscape

Key microneedle drug delivery device manufacturers are 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co. Ltd., Nanopass Tech, Corium International Inc., Valeritas Inc., Nitto Denko Corporation, Microdermics Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co. Ltd., Small Lab, and AdminMed nanoBioSciences LLC.

The global microneedle drug delivery systems market is dominated by large- and medium-sized companies. However, it is led by a few important companies that, as part of their marketing strategy, are focusing on their market and value chain positions.

Leading market companies employ a variety of strategies, including early market entry and deep penetration, as well as exclusive marketing and distribution licencing. However, due to the diverse character of market players, product innovation and differentiation are crucial market strategies for both, mid-size and large enterprises.

Regardless of their size, corporations use exclusive technology licencing and distribution rights acquisition as fundamental tactics. Aside from that, several of them are concentrating on strategic partnerships in order to acquire a competitive advantage.

Leading players operating in the global microneedle drug delivery equipment market are focusing on research & development to launch innovative products in the market. In addition to this, players are investing in mergers, acquisitions, and collaborations to gain a competitive edge in the market.

Microneedle Drug Delivery Systems Industry Report Scope

Attribute

Details

Forecast Period

2022-2030

Historical Data Available for

2015-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Product
  • End Use
  • Region

Key Companies Profiled

  • 3M Company
  • Becton
  • Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas Co. Ltd.
  • Nanopass Tech
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab
  • AdminMed nanoBioSciences LLC

Pricing

Available upon Request

Key Segments Of Microneedle Drug Delivery Systems Industry Survey

Microneedle Drug Delivery Systems Market by Product:

  • Solid Microneedles
    • Silicon
    • Metal
    • Polymer
  • Hollow Microneedles
  • Dissolving Microneedles

Microneedle Drug Delivery Systems Market by End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic Institutions
  • Research Institutes

Microneedle Drug Delivery Systems Market by Region:

  • North America Microneedle Drug Delivery Systems Market
  • Latin America Microneedle Drug Delivery Systems Market
  • Europe Microneedle Drug Delivery Systems Market
  • East Asia Microneedle Drug Delivery Systems Market
  • South Asia & Pacific Microneedle Drug Delivery Systems Market
  • Middle East & Africa (MEA) Microneedle Drug Delivery Systems Market

Frequently Asked Questions

The global microneedle drug delivery systems market is currently valued at around US$ 722.2 Mn and is predicted to top US$ 1.2 Bn by 2030.

Global demand for microneedle drug delivery systems is estimated to progress at a healthy CAGR of 6.6% through 2030.

Key microneedle drug delivery product manufacturers are 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co. Ltd., Nanopass Tech, Corium International Inc., Valeritas Inc., Nitto Denko Corporation, Microdermics Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co. Ltd., Small Lab, and AdminMed nanoBioSciences LLC.

North America is the largest market for microneedle drug delivery equipment.

Hospitals are the most dominant end users for microneedle drug delivery systems.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

    1.6. Transdermal Drug Delivery System Market  

        1.6.1. Global Market Overview (including Market Size)  

        1.6.2. Future Growth Prospect & Strategic Outlook  

        1.6.3. Opportunities (in terms of revenue generation)

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting The Market

    3.2. Advancement in Tissue Diagnostics 

4. Key Success Factors

    4.1. Product USPs and Adoption 

    4.2. Promotional Strategies,  by Key Manufacturers

    4.3. Patent Analysis

    4.4. Clinical Trial Analysis

        4.4.1. Clinical Trials by Region

        4.4.2. Analysis by Sponsor Type

        4.4.3. Analysis by Trial Phase

    4.5. Key Regulations

    4.6. Key Industry Deals

    4.7. Key Epidemiology of Needle Phobic Population 

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis

        5.4.1. Revenue By Product Type

        5.4.2. Revenue By Country

    5.5. 2022 Market Scenario

    5.6. Quarter by Quarter Forecast

    5.7. Projected recovery Quarter

    5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Microneedle Drug Delivery Systems Market Sales Analysis 2015-2021 and Forecast, 2022-2030

    6.1. Historical Market Volume (Mn Units) Analysis, 2015-2021

    6.2. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market - Pricing Analysis

    7.1. Regional Pricing Analysis, By Distribution Channel

    7.2. Global Average Pricing Analysis Benchmark

8. Global Microneedle Drug Delivery Systems Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022–2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Market Background

    9.1. Macro-Economic Factors

        9.1.1. Global GDP Growth Outlook

        9.1.2. Global Healthcare Expenditure Outlook

        9.1.3. Growth of Healthcare Sector in Emerging nations

    9.2. Forecast Factors - Relevance & Impact

        9.2.1. Disease Incidence/Prevalence Rate

        9.2.2. COVID 19 Pandemic Impact

        9.2.3. Top Companies Historical Growth

        9.2.4. Frequency of New Product Launches

        9.2.5. Treatment Cost (Microneedle Drug Delivery Systems)

        9.2.6. Per Patient Spending

    9.3. Market Dynamics

        9.3.1. Drivers

        9.3.2. Restraints

        9.3.3. Opportunity Analysis

10. Global Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2015 - 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022 - 2030

        10.3.1. Hollow Microneedles

        10.3.2. Solid Microneedles

            10.3.2.1. Silicon

            10.3.2.2. Metal

            10.3.2.3. Polymer

        10.3.3. Dissolving Microneedles 

    10.4. Market Attractiveness Analysis By Product Type 

11. Global Microneedle Drug Delivery Systems 2015-2021 and Forecast 2022-2030, by End Users

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End Users, 2015 - 2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End Users, 2021 - 2021

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

        11.3.3. Specialty Clinics

        11.3.4. Academic Institutions

        11.3.5. Research Institutes

    11.4. Market Attractiveness Analysis By End Users

12. Global Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015 - 2021

    12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021 - 2021

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. East Asia

        12.3.6. South Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis By Region

13. North America Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        13.4.1.  By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

        13.4.2. By Product Type

        13.4.3. By End Users

    13.5. Market Attractiveness Analysis

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

14. Latin America Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        14.4.1.  By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Argentina

            14.4.1.4. Rest of Latin America

        14.4.2. By Product Type

        14.4.3. By End Users

    14.5. Market Attractiveness Analysis

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

15. Europe Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        15.4.1.  By Country

            15.4.1.1. Germany

            15.4.1.2. Italy

            15.4.1.3. France

            15.4.1.4. U.K.

            15.4.1.5. Spain

            15.4.1.6. BENELUX

            15.4.1.7. Russia

            15.4.1.8. Rest of Europe

        15.4.2. By  Technology

        15.4.3. By End Users

    15.5. Market Attractiveness Analysis

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

16. South Asia Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        16.4.1.  By Country

            16.4.1.1. India

            16.4.1.2. Thailand

            16.4.1.3. Indonesia

            16.4.1.4. Malaysia

            16.4.1.5. Rest of South Asia

        16.4.2. By Product Type

        16.4.3. By End Users

    16.5. Market Attractiveness Analysis

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

17. East Asia Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        17.4.1.  By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

        17.4.2. By Product Type

        17.4.3. By End Users

    17.5. Market Attractiveness Analysis

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

18. Oceania Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        18.4.1.  By Country

            18.4.1.1. Australia

            18.4.1.2. New Zealand

        18.4.2. By Product Type

        18.4.3. By End Users

    18.5. Market Attractiveness Analysis

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis Microneedle Drug Delivery Systems 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2021

    19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2030

        19.4.1.  By Country

            19.4.1.1. GCC Countries

            19.4.1.2. South Africa

            19.4.1.3. Rest of Middle East and Africa

        19.4.2. By Product Type

        19.4.3. By End Users

    19.5. Market Attractiveness Analysis

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Microneedle Drug Delivery Systems Market Analysis 2015-2021 and Forecast 2022-2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Microneedle Drug Delivery Systems Market Analysis

        20.2.1. By Product Type

        20.2.2. By End User

    20.3. Canada Microneedle Drug Delivery Systems Market Analysis

        20.3.1. By Product Type

        20.3.2. By End User

    20.4. Mexico Microneedle Drug Delivery Systems Market Analysis

        20.4.1. By Product Type

        20.4.2. By End User

    20.5. Brazil Microneedle Drug Delivery Systems Market Analysis

        20.5.1. By Product Type

        20.5.2. By End User

    20.6. U.K. Microneedle Drug Delivery Systems Market Analysis

        20.6.1. By Product Type

        20.6.2. By End User

    20.7. Germany Microneedle Drug Delivery Systems Market Analysis

        20.7.1. By Product Type

        20.7.2. By End User

    20.8. France Microneedle Drug Delivery Systems Market Analysis

        20.8.1. By Product Type

        20.8.2. By End User

    20.9. Italy Microneedle Drug Delivery Systems Market Analysis

        20.9.1. By Product Type

        20.9.2. By End User

    20.10. Spain Microneedle Drug Delivery Systems Market Analysis

        20.10.1. By Product Type

        20.10.2. By End User

    20.11. BENELUX Microneedle Drug Delivery Systems Market Analysis

        20.11.1. By Product Type

        20.11.2. By End User

    20.12. Russia Microneedle Drug Delivery Systems Market Analysis

        20.12.1. By Product Type

        20.12.2. By End User

    20.13. China Microneedle Drug Delivery Systems Market Analysis

        20.13.1. By Product Type

        20.13.2. By End User

    20.14. Japan Microneedle Drug Delivery Systems Market Analysis

        20.14.1. By Product Type

        20.14.2. By End User

    20.15. South Korea Microneedle Drug Delivery Systems Market Analysis

        20.15.1. By Product Type

        20.15.2. By End User

    20.16. India Microneedle Drug Delivery Systems Market Analysis

        20.16.1. By Product Type

        20.16.2. By End User

    20.17. ASEAN Microneedle Drug Delivery Systems Market Analysis

        20.17.1. By Product Type

        20.17.2. By End User

    20.18. Australia Microneedle Drug Delivery Systems Market Analysis

        20.18.1. By Product Type

        20.18.2. By End User

    20.19. New Zealand Microneedle Drug Delivery Systems Market Analysis

        20.19.1. By Product Type

        20.19.2. By End User

    20.20. GCC Countries Microneedle Drug Delivery Systems Market Analysis

        20.20.1. By Product Type

        20.20.2. By End User

    20.21. Turkey Microneedle Drug Delivery Systems Market Analysis

        20.21.1. By Product Type

        20.21.2. By End User

    20.22. South Africa Microneedle Drug Delivery Systems Market Analysis

        20.22.1. By Product Type

        20.22.2. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Real-Time Bioprocess Raman Analyzer )

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional Footprint of Players

        21.4.2. Product Footprint by Players

        21.4.3. Channel Footprint by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Pricing Analysis by Competition

    22.3. Competition Benchmarking

    22.4. Competition Deep Dive 

        22.4.1. The 3M Company

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

                22.4.1.2.1. In-depth Product Analysis

            22.4.1.3. Pipeline Assessment

                22.4.1.3.1. Microneedle Drug Pipeline

                22.4.1.3.2. Clinical Trial Analysis

            22.4.1.4. Sales Footprint

            22.4.1.5. Analyst Commentary

        22.4.2. Becton, Dickinson and Company (BD)

            22.4.2.1. Overview

            22.4.2.2. Product Portfolio

                22.4.2.2.1. In-depth Product Analysis

            22.4.2.3. Pipeline Assessment

                22.4.2.3.1. Microneedle Drug Pipeline

                22.4.2.3.2. Clinical Trial Analysis

            22.4.2.4. Sales Footprint

            22.4.2.5. Analyst Commentary

        22.4.3. Zosano Pharma Corporation

            22.4.3.1. Overview

            22.4.3.2. Product Portfolio

                22.4.3.2.1. In-depth Product Analysis

            22.4.3.3. Pipeline Assessment

                22.4.3.3.1. Microneedle Drug Pipeline

                22.4.3.3.2. Clinical Trial Analysis

            22.4.3.4. Sales Footprint

            22.4.3.5. Analyst Commentary

        22.4.4. Raphas Co., Ltd. 

            22.4.4.1. Overview

            22.4.4.2. Product Portfolio

                22.4.4.2.1. In-depth Product Analysis

            22.4.4.3. Pipeline Assessment

                22.4.4.3.1. Microneedle Drug Pipeline

                22.4.4.3.2. Clinical Trial Analysis

            22.4.4.4. Sales Footprint

            22.4.4.5. Analyst Commentary

        22.4.5. Nanopass Tech

            22.4.5.1. Overview

            22.4.5.2. Product Portfolio

                22.4.5.2.1. In-depth Product Analysis

            22.4.5.3. Pipeline Assessment

                22.4.5.3.1. Microneedle Drug Pipeline

                22.4.5.3.2. Clinical Trial Analysis

            22.4.5.4. Sales Footprint

            22.4.5.5. Analyst Commentary

        22.4.6. Corium International, Inc.

            22.4.6.1. Overview

            22.4.6.2. Product Portfolio

                22.4.6.2.1. In-depth Product Analysis

            22.4.6.3. Pipeline Assessment

                22.4.6.3.1. Microneedle Drug Pipeline

                22.4.6.3.2. Clinical Trial Analysis

            22.4.6.4. Sales Footprint

            22.4.6.5. Analyst Commentary

        22.4.7. Valeritas, Inc.

            22.4.7.1. Overview

            22.4.7.2. Product Portfolio

                22.4.7.2.1. In-depth Product Analysis

            22.4.7.3. Pipeline Assessment

                22.4.7.3.1. Microneedle Drug Pipeline

                22.4.7.3.2. Clinical Trial Analysis

            22.4.7.4. Sales Footprint

            22.4.7.5. Analyst Commentary

        22.4.8. Nitto Denko Corporation

            22.4.8.1. Overview

            22.4.8.2. Product Portfolio

                22.4.8.2.1. In-depth Product Analysis

            22.4.8.3. Pipeline Assessment

                22.4.8.3.1. Microneedle Drug Pipeline

                22.4.8.3.2. Clinical Trial Analysis

            22.4.8.4. Sales Footprint

            22.4.8.5. Analyst Commentary

        22.4.9. Microdermics Inc.

            22.4.9.1. Overview

            22.4.9.2. Product Portfolio

                22.4.9.2.1. In-depth Product Analysis

            22.4.9.3. Pipeline Assessment

                22.4.9.3.1. Microneedle Drug Pipeline

                22.4.9.3.2. Clinical Trial Analysis

            22.4.9.4. Sales Footprint

            22.4.9.5. Analyst Commentary

        22.4.10. TheraJect, Inc.

            22.4.10.1. Overview

            22.4.10.2. Product Portfolio

                22.4.10.2.1. In-depth Product Analysis

            22.4.10.3. Pipeline Assessment

                22.4.10.3.1. Microneedle Drug Pipeline

                22.4.10.3.2. Clinical Trial Analysis

            22.4.10.4. Sales Footprint

            22.4.10.5. Analyst Commentary

        22.4.11. Vaxxas Pty Ltd.

            22.4.11.1. Overview

            22.4.11.2. Product Portfolio

                22.4.11.2.1. In-depth Product Analysis

            22.4.11.3. Pipeline Assessment

                22.4.11.3.1. Microneedle Drug Pipeline

                22.4.11.3.2. Clinical Trial Analysis

            22.4.11.4. Sales Footprint

            22.4.11.5. Analyst Commentary

        22.4.12. Endoderma Ltd.

            22.4.12.1. Overview

            22.4.12.2. Product Portfolio

                22.4.12.2.1. In-depth Product Analysis

            22.4.12.3. Pipeline Assessment

                22.4.12.3.1. Microneedle Drug Pipeline

                22.4.12.3.2. Clinical Trial Analysis

            22.4.12.4. Sales Footprint

            22.4.12.5. Analyst Commentary

        22.4.13. QuadMedicine

            22.4.13.1. Overview

            22.4.13.2. Product Portfolio

                22.4.13.2.1. In-depth Product Analysis

            22.4.13.3. Pipeline Assessment

                22.4.13.3.1. Microneedle Drug Pipeline

                22.4.13.3.2. Clinical Trial Analysis

            22.4.13.4. Sales Footprint

            22.4.13.5. Analyst Commentary

        22.4.14. SNvia Co., Ltd.

            22.4.14.1. Overview

            22.4.14.2. Product Portfolio

                22.4.14.2.1. In-depth Product Analysis

            22.4.14.3. Pipeline Assessment

                22.4.14.3.1. Microneedle Drug Pipeline

                22.4.14.3.2. Clinical Trial Analysis

            22.4.14.4. Sales Footprint

            22.4.14.5. Analyst Commentary

        22.4.15. Small Lab

            22.4.15.1. Overview

            22.4.15.2. Product Portfolio

                22.4.15.2.1. In-depth Product Analysis

            22.4.15.3. Pipeline Assessment

                22.4.15.3.1. Microneedle Drug Pipeline

                22.4.15.3.2. Clinical Trial Analysis

            22.4.15.4. Sales Footprint

            22.4.15.5. Analyst Commentary

        22.4.16. AdminMed nanoBioSciences LLC

            22.4.16.1. Overview

            22.4.16.2. Product Portfolio

                22.4.16.2.1. In-depth Product Analysis

            22.4.16.3. Pipeline Assessment

                22.4.16.3.1. Microneedle Drug Pipeline

                22.4.16.3.2. Clinical Trial Analysis

            22.4.16.4. Sales Footprint

            22.4.16.5. Analyst Commentary

23. Assumptions and Acronyms Use

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Microneedle Drug Delivery Device Market Volume (‘000 Units) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 02: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 03: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 04: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 05: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 06: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 07: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 08: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 09: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 10: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 11: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 12: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 13: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 14: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 15: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 16: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 17: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 19: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 20: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 21: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 22: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 23: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 24: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 25: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Microneedle Drug Delivery Device Market Volume (in Mn Units) Analysis, 2015-2021

Figure 02: Global Microneedle Drug Delivery Device Market Volume Forecast (in Mn Units), 2022-2030

Figure 03: Solid microneedle drug delivery system Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 04: Hollow microneedle drug delivery system Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 05: Dissolving microneedle drug delivery system Pricing Analysis (US$) for Per Unit (Per Micron), By Region, 2021

Figure 06: Global Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 07: Global Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 08: Global Microneedle Drug Delivery Device Market Absolute $ Opportunity, 2022 – 2030

Figure 09: Global Microneedle Drug Delivery Device Market Share Analysis (%), By Product Type, 2022-2030

Figure 10: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By Product Type, 2022-2030

Figure 11: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 12: Global Microneedle Drug Delivery Device Market Share Analysis (%), By End User, 2022-2030

Figure 13: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By End User, 2022-2030

Figure 14: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By End User, 2022-2030

Figure 15: Global Microneedle Drug Delivery Device Market Share Analysis (%), By Region, 2022-2030

Figure 16: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By Region, 2022-2030

Figure 17: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By Region, 2022-2030

Figure 18: North America Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 19: North America Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 20: North America Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 21: North America Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 22: North America Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 23: North America Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 24: North America Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 25: North America Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 26: Latin America Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 27: Latin America Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 28: Latin America Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 29: Latin America Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 30: Latin America Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 31: Latin America Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 32: Latin America Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 33: Latin America Microneedle Drug Delivery Device Market Analysis by Country, 2022-2030

Figure 34: Europe Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 35: Europe Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 36: Europe Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 37: Europe Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 38: Europe Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 39: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 40: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 41: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 42: South Asia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 43: South Asia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 44: South Asia Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 45: South Asia Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 46: South Asia Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 47: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 48: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 49: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 50: East Asia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 51: East Asia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 52: East Asia Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 53: East Asia Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 54: East Asia Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 55: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 56: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 57: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 58: Oceania Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 59: Oceania Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 60: Oceania Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 61: Oceania Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 62: Oceania Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 63: Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 64:Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 65: Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 66: MEA Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 67: MEA Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 68: MEA Microneedle Drug Delivery Device Market Value Share, By Country, 2022 (E)

Figure 69: MEA Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2021

Figure 70: MEA Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2022-2030

Figure 71: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2022-2030

Figure 72: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2022-2030

Figure 73: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2022-2030

Figure 74: U. S. Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 75: U. S. Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 76: Canada Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 77: Canada Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 78: Mexico Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 79: Mexico Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 80: Brazil Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 81: Brazil Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 82: U.K. Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 83: U.K. Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 84: Germany Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 85: Germany Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 86: France Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 87: France Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 88: Italy Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 89: Italy Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 90: Spain Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 91: Spain Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 92: Russia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 93: Russia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 94: China Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 95: China Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 96: Japan Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 97: Japan Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 98: South Korea Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 99: South Korea Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 100: India Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 101: India Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 102: Thailand Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 103: Thailand Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 104: Indonesia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 105: Indonesia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 106: Malaysia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 107: Malaysia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 108: Australia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 109: Australia Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 110: New Zealand Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 111: New Zealand Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 112: GCC Countries Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 113: GCC Countries Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 114: Turkey Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 115: Turkey Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Figure 116: South Africa Microneedle Drug Delivery Device Market Value Share, By Product Type, 2022 (E)

Figure 117: South Africa Microneedle Drug Delivery Device Market Value Share, By End User, 2022 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pharmaceutical Drug Delivery Market

Published : February 2022

Healthcare

Prescription Delivery Services Market

Published : September 2020

Healthcare

Connected Drug Delivery Devices Market

Published : December 2021

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Microneedle Drug Delivery Systems Market